Abstract
Rheumatic fever is a multisystem inflammatory disease that occurs as a delayed sequel to group A streptococcal pharyngitis. It is less common than it was 50 years ago but is still a major cause of heart disease in developing areas of the world. The relationship between the site of infection, the type of causative organism, and susceptibility of the host is essential in the development of the disease. Its major clinical manifestations include carditis, migratory polyarthritis, chorea, erythema marginatum, and subcutaneous nodules. It can manifest as an acute febrile illness consisting of migratory polyarthritis involving the large joints, as carditis and valvulitis, or as Sydenham’s chorea with involvement of the central nervous system. The disorder in its milder form resolves itself without sequelae. Carditis is the condition most associated with increased mortality and morbidity and may be fatal in its severe forms. Penicillin is the most appropriate primary and secondary prophylaxis. Antiinflammatory agents provide symptomatic relief but do not prevent rheumatic heart disease.
Similar content being viewed by others
References and Recommended Reading
Bisno AL: The resurgence of acute rheumatic fever in the United States. Ann Rev Med 1990, 41:319–329.
Kaplan EL: T. Duckett Jones Memorial Lecture. Global assessment of rheumatic fever and rheumatic heart disease at the close of the century. Influences and dynamics of populations and pathogens: a failure to realize prevention? Circulation 1993, 88:1964–1972.
Zamman MM, Yoshiike N, Chowdhury AH, et al.:Socioeconomic deprivation associated with acute rheumatic fever: a hospital-based case-control study in Bangladesh. Pediatr Perinatal Epidemiol 1997, 11:322–332.
Da Silva NA, Faira BA: Acute rheumatic fever, still a challenge. Rheum Clin North Am 1997, 23:545–568.
Stollerman GH: Rheumatic fever. Lancet 1997, 349:935–942.
Fauci A, et al.: Harrison’s Principles of Internal Medicine. New York: McGraw-Hill; 1998:1309–1311.
Gibofsky A, Kerwar S, Zabriskie J: Rheumatic fever: the relationship between host, microbe, and genetics. Rheum Dis Clin North Am 1998, 24:237–261. Comprehensive review of acute rheumatic fever.
Brandt ER, Currie B, Mammo L, Pruksakorn S, Good MF: Can class I epitope of M protein be a diagnostic marker for rheumatic fever in populations endemic for group A streptococcus? Lancet 1998, 351:1860.
Marquez-Diaz MA: Sydenham’s chorea. Psychiatr Clin North Am 1997, 156:25–29.
Yegin O, Coskin M, Ertug H: Cytokines in acute rheumatic fever. Eur J Pediatr 1997, 156:25–29.
Bhatnagar A, Grover A, Ganguly NK: Super-antigen induced T cell responses in acute rheumatic fever and chronic rheumatic heart disease patients. Clin Exp Immunol 1999, 116:100–106.
Guedez Y, Kotby A, El-Demellawy M, et al.: HLA class II association with rheumatic heart disease is more evident and consistent among clinically homogeneous patients. Circulation 1999, 99:2784–2790.
Gerbase-DeLima M, Scala LCN, Temin J, Santos DV, Otto PA:Rheumatic fever and the HLA complex: a co-segregation study. Circulation 1994, 89:138–141.
Brandt ER, Hayman WA, Currie B, et al.: Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococcus from Australian Aboriginal endemic communities. Int Immunol 1999, 11:569–576.
Thatai D, Zoiten G: Current guidelines for the treatment of patients with rheumatic fever. Drugs 1999, 57:545–555.
Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki’s Disease of the Council on Cardiovascular Medicine: Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. JAMA 1992, 268:2069–2073.
Khaled A, Majeed HA: Acute rheumatic fever: diagnosis and treatment. Pediatr Ann 1998, 27:295–300.
Capizzi SA, Levy NT, Enrique-Sarano M: Rheumatic fever revisited. Postgrad Med J 1997, 102:65–71.
Pinals RS: Polyarthritis and fever. N Engl J Med 1994, 330:769–764. Excellent article comparing different types of arthritis.
Narula J, Malhotra A, Yasuda T, et al.: Usefulness of antimyosin antibody imaging for the detection of active rheumatic myocarditis. Am J Cardiol 1999, 84:946–949.
Narula J, Chandrasekhar Y, Rahimtoola S: Diagnosis of active rheumatic carditis: the echoes of change. Circulation 1999, 100:1576–1581.
Elevi M, Celebi A, Tombul T, Gokalp SA: Cardiac involvement in Sydenham’s chorea: clinical and Doppler echocardiography findings. Acta Paediatrica 1999, 88:1074–1077.
Swedo SE, Leonard HL, Garvey M, et al.: Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the fist 50 cases. Am J Psychiatr 1998, 155:264–271.
Aviles RJ, Ramakrishna G, Mohr DN, Michet CJ: Poststreptococcal reactive arthritis in adults: a case series. Mayo Clin Proc 2000, 75:144–147.
Moon RJ, Greene MG, Rehe GT, Katona IM: Poststreptococcal reactive arthritis in children: a potential predecessor of rheumatic heart disease. J Rheumatol 1995, 22:529–553.
Bisno AL: Group A streptococcal infection and acute rheumatic fever. N Engl J Med 1991, 325:783–793.
Jansen TL, Janssen M, Jong AJ, Jeurissen ME: Post-streptococcal reactive arthritis: a clinical and serological description, revealing its distinction from acute rheumatic fever. J Intern Med 1999, 245:261–267.
Gutierrez-Urena S, Molina J, Molina JF: Poststreptococcal reactive arthritis, clinical course, and outcome in 6 adult patients. J Rheumatol 1995, 22:1710–1713.
Deighton C: Beta haemolytic streptococci and reactive arthritis in adults. Ann Rheum Dis 1993, 52:475–482.
Schattner A: Poststreptococcal reactive rheumatic syndrome. J Rheumatol 1996, 23:1297–1298.
Gerber MA: Antibiotic resistance: relationship to persistence of group A streptococci in the upper respiratory tract. Pediatrics 1996, 97:971–975.
Shulman ST: Evaluation of penicillins, cephalosporins, and macrolides for therapy of streptococcal pharyngitis. Pediatrics 1996, 97:955–959.
Bisno AL, Gerber MA, Gwaltney JM, et al.: Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Clin Infect Dis 1997, 25:574–583.
Albert DA, Harrison HL: The treatment of rheumatic carditis: a review and meta-analysis. Medicine 1995, 74:1–12.
Osmon DR: Antimicrobial prophylaxis in adults. Mayo Clin Proc 2000, 75:98–109.
Snitcowsky R: Rheumatic fever prevention in industrializing countries: problems and approaches. Pediatrics 1996, 97:996–998.
Lue HC, Wu MH, Wang JR, Wu FF, Wu YN: Three-versus four-week administration of benzathine penicillin G: effects on incidence of streptococcal infections and recurrences of rheumatic fever. Pediatrics 1996, 97:984–988.
Markowitz M, Lue HC: Allergic reactions in rheumatic fever patients on long-term benzathine penicillin G: the role of skin testing for penicillin allergy. Pediatrics 1996, 97:981–983.
Bisno AL: Acute pharyngitis: etiology and diagnosis. Pediatrics 1996, 97:949–954.
Dale JB: Group A streptococcal vaccines. Pediatr Ann 1998, 27:301–307.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rullan, E., Sigal, L.H. Rheumatic fever. Curr Rheumatol Rep 3, 445–452 (2001). https://doi.org/10.1007/s11926-996-0016-4
Issue Date:
DOI: https://doi.org/10.1007/s11926-996-0016-4